Peer-influenced content. Sources you trust. No registration required. This is HCN.
Medical Professionals Reference (MPR)
FDA’s approval of Opill, the first over-the-counter daily oral contraceptive, marks a major shift in contraceptive accessibility, opening new pathways in the prevention of unintended pregnancies.
Family Medicine/General Practice July 20th 2023
DentistryIQ
As the FDA approves the first over-the-counter oral contraceptive, dental professionals must be cognizant of potential impacts on oral health and patient management.
Dentistry July 17th 2023
British Medical Journal (The BMJ)
Emerging research uncovers potential associations between the use of menopausal hormone therapy and an increased risk of dementia, including Alzheimer’s disease. Discover more about the implications of these findings for women’s health management.
Neurology July 11th 2023
Pharmacy Today
Learn how pharmacists can dramatically improve access to reproductive health care, from removing obstacles to care to putting sexual and reproductive health services in place. Find out more about how you might contribute to this transition.
Clinical Pharmacology June 30th 2023
MDLinx
As physicians, we find ourselves at the forefront of a worrying trend – the rising incidence of early-onset cancers. To counter this, we must employ a multifaceted approach, embracing prevention, early detection, and strategic interventions.
Internal Medicine June 29th 2023
Healthgrades for Professionals
With research hinting at potential links between vitamin B6 and various health benefits, it’s time for physicians to delve deeper into the role of this micronutrient in optimizing patient health.
Cardiology June 28th 2023